Dolby Laboratories (NYSE:DLB - Get Free Report)'s stock had its "outperform" rating reissued by investment analysts at Barrington Research in a note issued to investors on Friday,Benzinga reports. They currently have a $100.00 price objective on the electronics maker's stock. Barrington Research's price target would suggest a potential upside of 38.56% from the company's current price.
A number of other equities analysts also recently issued reports on DLB. Wall Street Zen upgraded shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a report on Saturday, August 30th. Robert W. Baird started coverage on shares of Dolby Laboratories in a research note on Friday, September 5th. They issued a "neutral" rating and a $74.00 price objective on the stock. Rosenblatt Securities reissued a "buy" rating and issued a $95.00 price objective on shares of Dolby Laboratories in a research note on Friday, August 1st. Baird R W raised shares of Dolby Laboratories to a "hold" rating in a research note on Friday, September 5th. Finally, Tigress Financial increased their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the company a "buy" rating in a research note on Friday, August 15th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $95.75.
View Our Latest Stock Analysis on DLB
Dolby Laboratories Stock Up 1.7%
Shares of DLB opened at $72.17 on Friday. The company has a 50-day simple moving average of $73.81 and a 200-day simple moving average of $75.60. The company has a market capitalization of $6.92 billion, a PE ratio of 26.44 and a beta of 0.93. Dolby Laboratories has a 52-week low of $68.24 and a 52-week high of $89.66.
Dolby Laboratories (NYSE:DLB - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. The business had revenue of $315.55 million during the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The business's revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, research analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current year.
Insider Activity
In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the firm's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $72.31, for a total transaction of $1,807,750.00. Following the sale, the chief executive officer directly owned 114,725 shares of the company's stock, valued at $8,295,764.75. This trade represents a 17.89% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Shriram Revankar sold 7,000 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the transaction, the senior vice president owned 70,435 shares in the company, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 99,366 shares of company stock worth $7,352,963 over the last ninety days. 38.39% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the stock. Alpine Bank Wealth Management purchased a new position in shares of Dolby Laboratories during the 1st quarter worth about $25,000. Cheviot Value Management LLC purchased a new position in shares of Dolby Laboratories during the 1st quarter worth about $27,000. MAI Capital Management lifted its holdings in shares of Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker's stock worth $28,000 after acquiring an additional 162 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in shares of Dolby Laboratories during the 1st quarter worth about $29,000. Finally, Allworth Financial LP lifted its holdings in shares of Dolby Laboratories by 590.4% during the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker's stock worth $37,000 after acquiring an additional 431 shares during the period. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
About Dolby Laboratories
(
Get Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.